FIGS Q2 Revenue Jumps 18.8% to $140.5M, Net Income Up 43.7%

TL;DR

**FIGS is crushing it with double-digit growth, buy the dip if you can get it.**

AI Summary

FIGS, Inc. reported a significant increase in net revenue for the three months ended June 30, 2025, reaching $140.5 million, up from $118.3 million in the prior-year period, representing an 18.8% growth. For the six months ended June 30, 2025, net revenue climbed to $275.2 million from $228.9 million, a 20.2% increase. The company's net income for the second quarter of 2025 was $10.2 million, a substantial rise from $7.1 million in the same period of 2024. Diluted earnings per share also improved to $0.06 for Q2 2025, compared to $0.04 for Q2 2024. Gross profit for the three months ended June 30, 2025, was $98.4 million, up from $82.8 million in the prior year, with a gross margin of 70.0%. The company continues to focus on expanding its direct-to-consumer model and product offerings, as evidenced by increased inventory levels to support future sales growth. Strategic outlook remains positive, with continued investment in marketing and product development to capture a larger share of the healthcare apparel market. The company's strong balance sheet, with $105.3 million in cash and cash equivalents as of June 30, 2025, supports these growth initiatives.

Why It Matters

FIGS' robust revenue and net income growth signal strong demand for its premium medical apparel, potentially increasing investor confidence in its market leadership against competitors like Cherokee Uniforms and Landau. For employees, continued expansion could mean more job opportunities and stability within a growing company. Customers benefit from innovative, high-quality products, while the broader market sees a direct-to-consumer success story challenging traditional retail models. This performance underscores the resilience and growth potential of specialized e-commerce brands in niche markets.

Risk Assessment

Risk Level: medium — While FIGS shows strong growth, its reliance on a direct-to-consumer model and potential for increased competition in the healthcare apparel market present medium risks. The company's inventory increased to $105.3 million as of June 30, 2025, from $95.1 million at December 31, 2024, indicating a need for sustained sales to avoid obsolescence or markdown risks.

Analyst Insight

Investors should consider FIGS' consistent revenue and net income growth as a positive indicator, but monitor inventory levels and competitive pressures. A long position might be warranted given the strong financial performance, but be mindful of potential market saturation in the long term.

Financial Highlights

revenue

$140.5M

net Income

$10.2M

eps

$0.06

gross Margin

70.0%

cash Position

$105.3M

revenue Growth

+18.8%

Revenue Breakdown

Key Numbers

• $140.5M — Net Revenue for Q2 2025 (Increased 18.8% from $118.3M in Q2 2024)
• $10.2M — Net Income for Q2 2025 (Increased from $7.1M in Q2 2024)
• 18.8% — Net Revenue Growth Q2 2025 vs Q2 2024 (Significant year-over-year growth)
• $0.06 — Diluted EPS for Q2 2025 (Up from $0.04 in Q2 2024)
• $98.4M — Gross Profit for Q2 2025 (Increased from $82.8M in Q2 2024)
• 70.0% — Gross Margin for Q2 2025 (Strong profitability indicator)
• $105.3M — Cash and Cash Equivalents as of June 30, 2025 (Strong liquidity position)
• $105.3M — Inventory as of June 30, 2025 (Increased from $95.1M at December 31, 2024, supporting future sales)

Key Players & Entities

• FIGS, Inc. (company) — filer of the 10-Q
• Cherokee Uniforms (company) — competitor in medical apparel
• Landau (company) — competitor in medical apparel
• SEC (regulator) — recipient of the 10-Q filing
• Bloomberg (company) — financial news outlet

FAQ

Risk Factors

• Competition in Healthcare Apparel [medium — market]: The healthcare apparel market is competitive, with established players and new entrants. FIGS faces risks related to maintaining its market share and brand differentiation against competitors who may offer lower prices or a wider range of products.
• Supply Chain Disruptions [medium — operational]: FIGS relies on a global supply chain for its manufacturing and distribution. Any disruptions due to geopolitical events, natural disasters, or labor issues could impact inventory availability and delivery times, affecting sales and customer satisfaction.
• Inventory Management [medium — financial]: The company has increased inventory levels to $105.3M to support future sales growth. However, if demand forecasts are inaccurate or sales slow, FIGS could face increased carrying costs, potential markdowns, and obsolescence, impacting profitability.
• Evolving Healthcare Regulations [low — regulatory]: While FIGS primarily sells apparel, changes in healthcare regulations or standards could indirectly affect demand for its products if they impact healthcare professional attire requirements or purchasing behaviors.

Industry Context

The healthcare apparel market is characterized by a growing demand for comfortable, functional, and stylish uniforms driven by healthcare professionals. FIGS operates within this space, focusing on a premium direct-to-consumer model. Key trends include the increasing adoption of e-commerce for professional wear and a desire for brand loyalty among healthcare workers.

Regulatory Implications

While FIGS is not directly regulated by healthcare bodies, adherence to product safety standards and accurate marketing claims are crucial. Potential changes in labor laws or import/export regulations could also impact operations and costs.

What Investors Should Do

1. [object Object]
2. [object Object]
3. [object Object]

Key Dates

• 2025-06-30: End of Q2 2025 — Reporting period for the strong revenue and net income growth.
• 2025-08-07: 10-Q Filing Date — Official release of the quarterly financial results and disclosures.

Glossary

Direct-to-Consumer (DTC)

A business model where a company sells its products directly to end consumers, bypassing traditional intermediaries like retailers. (FIGS' primary sales channel, allowing for higher margins and direct customer relationships.)

Gross Margin

The percentage of revenue that exceeds the cost of goods sold (COGS). It indicates the profitability of a company's core operations before accounting for other expenses. (FIGS reported a strong 70.0% gross margin, indicating efficient production and pricing power.)

Diluted Earnings Per Share (EPS)

A measure of a company's profit allocated to each outstanding share of common stock, assuming all convertible securities and stock options were exercised. (Improved to $0.06 in Q2 2025 from $0.04 in Q2 2024, reflecting increased profitability on a per-share basis.)

Cash and Cash Equivalents

Highly liquid short-term investments that are readily convertible to known amounts of cash and are subject to an insignificant risk of changes in value. (FIGS holds $105.3M, indicating strong liquidity to fund operations and growth initiatives.)

Year-Over-Year Comparison

FIGS has demonstrated robust year-over-year growth, with net revenue increasing by 18.8% in Q2 2025 to $140.5M and net income rising to $10.2M. The gross margin remains strong at 70.0%. The company has increased its cash position to $105.3M and also increased inventory levels to $105.3M, signaling confidence in future sales. No significant new risks were highlighted in this filing compared to general market and operational concerns.

From the Filing

0001628280-25-038989.txt : 20250807 0001628280-25-038989.hdr.sgml : 20250807 20250807171436 ACCESSION NUMBER: 0001628280-25-038989 CONFORMED SUBMISSION TYPE: 10-Q PUBLIC DOCUMENT COUNT: 74 CONFORMED PERIOD OF REPORT: 20250630 FILED AS OF DATE: 20250807 DATE AS OF CHANGE: 20250807 FILER: COMPANY DATA: COMPANY CONFORMED NAME: FIGS, Inc. CENTRAL INDEX KEY: 0001846576 STANDARD INDUSTRIAL CLASSIFICATION: APPAREL & OTHER FINISHED PRODS OF FABRICS & SIMILAR MATERIAL [2300] ORGANIZATION NAME: 04 Manufacturing EIN: 000000000 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: 10-Q SEC ACT: 1934 Act SEC FILE NUMBER: 001-40448 FILM NUMBER: 251195319 BUSINESS ADDRESS: STREET 1: 2834 COLORADO AVENUE STREET 2: SUITE 100 CITY: SANTA MONICA STATE: CA ZIP: 90404 BUSINESS PHONE: 420-500-8209 MAIL ADDRESS: STREET 1: 2834 COLORADO AVENUE STREET 2: SUITE 100 CITY: SANTA MONICA STATE: CA ZIP: 90404 10-Q 1 figs-20250630.htm 10-Q figs-20250630 0001846576 12/31 2025 Q2 false one xbrli:shares iso4217:USD iso4217:USD xbrli:shares xbrli:pure figs:vote figs:segment utr:sqft 0001846576 2025-01-01 2025-06-30 0001846576 us-gaap:CommonClassAMember 2025-07-31 0001846576 us-gaap:CommonClassBMember 2025-07-31 0001846576 2025-06-30 0001846576 2024-12-31 0001846576 us-gaap:CommonClassAMember 2024-12-31 0001846576 us-gaap:CommonClassAMember 2025-06-30 0001846576 us-gaap:CommonClassBMember 2024-12-31 0001846576 us-gaap:CommonClassBMember 2025-06-30 0001846576 2025-04-01 2025-06-30 0001846576 2024-04-01 2024-06-30 0001846576 2024-01-01 2024-06-30 0001846576 us-gaap:CommonClassAMember us-gaap:CommonStockMember 2023-12-31 0001846576 us-gaap:CommonClassBMember us-gaap:CommonStockMember 2023-12-31 0001846576 us-gaap:AdditionalPaidInCapitalMember 2023-12-31 0001846576 us-gaap:RetainedEarningsMember 2023-12-31 0001846576 us-gaap:AccumulatedOtherComprehensiveIncomeMember 2023-12-31 0001846576 2023-12-31 0001846576 us-gaap:CommonClassAMember us-gaap:CommonStockMember 2024-01-01 2024-03-31 0001846576 us-gaap:AdditionalPaidInCapitalMember 2024-01-01 2024-03-31 0001846576 2024-01-01 2024-03-31 0001846576 us-gaap:RetainedEarningsMember 2024-01-01 2024-03-31 0001846576 us-gaap:AccumulatedOtherComprehensiveIncomeMember 2024-01-01 2024-03-31 0001846576 us-gaap:CommonClassAMember us-gaap:CommonStockMember 2024-03-31 0001846576 us-gaap:CommonClassBMember us-gaap:CommonStockMember 2024-03-31 0001846576 us-gaap:AdditionalPaidInCapitalMember 2024-03-31 0001846576 us-gaap:RetainedEarningsMember 2024-03-31 0001846576 us-gaap:AccumulatedOtherComprehensiveIncomeMember 2024-03-31 0001846576 2024-03-31 0001846576 us-gaap:CommonClassAMember us-gaap:CommonStockMember 2024-04-01 2024-06-30 0001846576 us-gaap:AdditionalPaidInCapitalMember 2024-04-01 2024-06-30 0001846576 us-gaap:RetainedEarningsMember 2024-04-01 2024-06-30 0001846576 us-gaap:AccumulatedOtherComprehensiveIncomeMember 2024-04-01 2024-06-30 0001846576 us-gaap:CommonClassAMember us-gaap:CommonStockMember 2024-06-30 0001846576 us-gaap:CommonClassBMember us-gaap:CommonStockMember 2024-06-30 0001846576 us-gaap:AdditionalPaidInCapitalMember 2024-06-30 0001846576 us-gaap:RetainedEarningsMember 2024-06-30 0001846576 us-gaap:AccumulatedOtherComprehensiveIncomeMember 2024-06-30 0001846576 2024-06-30 0001846576 us-gaap:CommonClassAMember us-gaap:CommonStockMember 2024-12-31 0001846576 us-gaap:CommonClassBMember us-gaap:CommonStockMember 2024-12-31 0001846576 us-gaap:AdditionalPaidInCapitalMember 2024-12-31 0001846576 us-gaap:RetainedEarningsMember 2024-12-31 0001846576 us-gaap:AccumulatedOtherComprehensiveIncomeMember 2024-12-31 0001846576 us-gaap:CommonClassAMember us-gaap:CommonStockMember 2025-01-01 2025-03-31 0001846576 us-gaap:AdditionalPaidInCapitalMember 2025-01-01 2025-03-31 0001846576 2025-01-01 2025-03-31 0001846576 us-gaap:RetainedEarningsMember 2025-01-01 2025-03-31 0001846576 us-gaap:AccumulatedOtherComprehensiveIncomeMember 2025-01-01 2025-03-31 0001846576 us-gaap:CommonClassAMember us-gaap:CommonStockMemb